The COVID-19 pandemic has highlighted the necessity for speedy and correct molecular diagnostic testing to handle rising infectious illnesses. Conventional testing paradigms contain sending samples to reference laboratories, resulting in delays in acquiring outcomes. Moreover, present testing strategies are sometimes advanced and require specialised infrastructure, limiting entry to testing in sure settings.
QUASR Diagnostics, an organization based throughout the COVID-19 epidemic, goals to develop the subsequent era of molecular diagnostic testing expertise to handle these challenges. The corporate is commercializing expertise licensed from Sandia Labs to develop speedy, point-of-care, in-field, or at-home genetic assessments.
QUASR Diagnostics has developed a revolutionary expertise that addresses the constraints of the present testing paradigm. The expertise permits testing to be carried out anyplace, from dwelling to public venues and healthcare organizations, eliminating the necessity for samples to be despatched to reference laboratories, bettering entry to testing, and decreasing the time wanted to acquire outcomes.
QUASR Diagnostics’ expertise offers check leads to lower than half-hour, enabling well timed healthcare choices and group engagement with out the necessity for classy logistics. Moreover, the expertise permits for correct testing on easy-to-collect samples, which is inconceivable with conventional speedy assessments or delicate assessments requiring specialised infrastructure. This enchancment in accuracy and accessibility makes testing more practical and environment friendly.
As healthcare democratization positive aspects traction, there’s a rising want for autonomy in decision-making primarily based on out there information. To deal with this want, QUASR Diagnostics’ expertise offers easy-to-use, at-home check kits for numerous infectious illness brokers. This empowers people to take management of their well being, make knowledgeable choices, and defend themselves and people round them.
The corporate can also be addressing different areas the place molecular diagnostic testing expertise could make an affect. For instance, QUASR Diagnostics is growing an automatic testing platform for urinary tract infections to be used in physician’s workplaces, bettering the effectivity and accuracy of testing. The corporate can also be growing in-field devices and check kits for non-healthcare markets, equivalent to agriculture and veterinary functions, to determine and stop the unfold of infectious illnesses in livestock and crops.
QUASR Diagnostics is working to deliver this expertise to market as shortly as doable to handle the continued COVID-19 pandemic and future rising infectious illnesses. As well as, the corporate goals to offer speedy and correct testing expertise accessible to everybody, no matter location or infrastructure.
The continuing COVID-19 pandemic highlighted the necessity for speedy and correct molecular diagnostic testing expertise. QUASR Diagnostics is addressing the constraints of the present testing paradigm by growing expertise for speedy testing that may be performed at point-of-care, in-field, or at dwelling. The corporate’s expertise streamlines testing, offering quick, correct outcomes on easy-to-collect samples. Moreover, QUASR Diagnostics is addressing different areas the place molecular diagnostic testing expertise can affect, equivalent to healthcare, agriculture, and veterinary functions. With the corporate’s expertise, people can take management of their well being and make knowledgeable choices primarily based on out there information. To study extra, go to the corporate’s web site at https://quasrdx.com/